A first-in-human clinical study to test the safety and preliminary efficacy of CDNF in Parkinson's disease

被引：0
|
作者：
Huttunen, H.
Booms, S.
Koskinen, J.
Saarma, M.
机构：
来源：
MOVEMENT DISORDERS | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
414
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 50 条
  • [1] Update on the First-in-Human Clinical Study Evaluating Neural Stem Cells in Patients with Parkinson's Disease
    Kern, Russell
    Garitaonandia, Ibon
    Gonzalez, Rodolfo
    Abramihina, Tatiana
    Sherman, Glenn
    Noskov, Alexander
    Semechkin, Andrey
    Shahrul, Azmin
    Nair, Girish
    Evans, Andrew
    MOLECULAR THERAPY, 2017, 25 (05) : 140 - 140
  • [2] Phase I-II first-in-human clinical study of intraputamenal CDNF in Parkinson's disease: Exploratory PET imaging endpoints of the 12-month treatment period
    Kerstens, V.
    Fazio, P.
    Johansson, J.
    Granberg, T.
    Booms, S.
    Huttunen, H.
    Sjogren, M.
    Woolley, M.
    Murphy, B.
    Fielder, P.
    Baker, J.
    Skinner, P.
    Andreasson, M.
    Paul-Visse, G.
    Kivisaari, R.
    Bjartmarz, H.
    Lind, G.
    Almqvist, P.
    Scheperjans, F.
    Widner, H.
    Svenningsson, P.
    Rinne, J.
    Varrone, A.
    MOVEMENT DISORDERS, 2020, 35 : S403 - S403
  • [3] Fetal porcine cell transplantation for the treatment of Parkinson's disease: Preliminary clinical safety, efficacy and PERV test results
    Dinsmore, JH
    Jacoby, D
    Ellias, SA
    Palmer, EP
    Kott, HS
    Schumacher, J
    Manhart, C
    Raineri, R
    Moore, A
    Fink, JS
    Stewart, GR
    EXPERIMENTAL NEUROLOGY, 1998, 153 (02) : 372 - 372
  • [4] Pharmacology and Toxicology Studies Conducted for the First-in-Human Clinical Study of Neural Stem Cells in Parkinson's Disease
    Gonzalez, Rodolfo
    Garitaonandia, Ibon
    Abramihina, Tatiana
    Sherman, Glenn
    Noskov, Alexander
    Christiansen-Weber, Trudy
    Semechkin, Andrey
    Redmond, D. Eugene
    Snyder, Evan Y.
    Kern, Russell
    MOLECULAR THERAPY, 2017, 25 (05) : 140 - 140
  • [5] Phase I-II first-in-human clinical trial of intraputamenal CDNF in Parkinson's disease: Exploratory fluid-based biomarker endpoints of the 12-month treatment period
    Huttunen, H.
    Booms, S.
    Abdesselem, H.
    Majbour, N.
    El-Agnaf, O.
    Poggiolini, I.
    Parkkinen, L.
    Cryar, A.
    Sirka, E.
    Harris, J.
    Dove, M.
    Sjogren, M.
    Woolley, M.
    Murphy, B.
    Fielder, P.
    Baker, J.
    Skinner, P.
    Andreasson, M.
    Paul-Visse, G.
    Kivisaari, R.
    Bjartmarz, H.
    Almqvist, P.
    Lind, G.
    Scheperjans, F.
    Widner, H.
    Svenningsson, P.
    MOVEMENT DISORDERS, 2020, 35 : S400 - S401
  • [6] Launching Invasive, First-in-Human Trials Against Parkinson's Disease: Ethical Considerations
    Kimmelman, Jonathan
    London, Alex John
    Ravina, Bernard
    Ramsay, Tim
    Bernstein, Mark
    Fine, Alan
    Stahnisch, Frank W.
    Emborg, Marina Elena
    MOVEMENT DISORDERS, 2009, 24 (13) : 1893 - 1901
  • [7] Challenges in trial design for a first-in-human clinical trial of stem cell-based transplantation in Parkinson's disease: the Parkinson's neurologist's perspective
    Sarva, H.
    Lee, A.
    Hellmers, N.
    Henchcliffe, C.
    MOVEMENT DISORDERS, 2019, 34 : S14 - S14
  • [8] Efficacy and Safety of Novel NovaCross Microcatheter for Chronic Total Occlusions: First-in-Human Study
    Walsh, Simon
    Dudek, Dariusz
    Bryniarski, Leszek
    Assali, Abid
    Danenberg, Haim
    Lotan, Chaim
    Hanratty, Colm
    Wilkolek, Piotr
    Kornowski, Ran
    JOURNAL OF INVASIVE CARDIOLOGY, 2016, 28 (03): : 88 - 91
  • [9] First-in-human intrathecal gene transfer study for giant axonal neuropathy: Preliminary review of long-term efficacy and safety
    Bharucha-Goebel, D.
    Saade, D.
    Todd, J.
    Norato, G.
    Jain, M.
    Waite, M.
    Armao, D.
    Foley, A.
    Lehky, T.
    Averion, G.
    Hu, Y.
    Mohassel, P.
    Hoke, A.
    DeLong, T.
    Acquaye, N.
    Hinkley, L.
    Chichester, J.
    Mendoza, C.
    Soldatos, A.
    Gray, S.
    Bonnemann, C.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S94 - S94
  • [10] Challenges to Informed Consent in First-In-Human Trials Involving Novel Treatments: A Case Study of Parkinson's Disease
    Hug, Kristina
    Johansson, Mats
    JOURNAL OF PARKINSONS DISEASE, 2017, 7 (04) : 695 - 702
12345